Document is current
Any future updates will be listed below
-
Authors
Luo, Mingjia
Ballester, Maria Pilar
Soffientini, Ugo
Jalan, Rajiv
Mehta, Gautam https://orcid.org/0000-0002-5696-359X
-
Funding
Funding for this research was provided by:
Instituto de Salud Carlos III (CM19/00011)
- License Information
-
More Information
Article History
Received: 21 January 2022
Accepted: 7 May 2022
First Online: 29 June 2022
Declarations
:
: RJ has research collaborations with Takeda and Yaqrit, consults for Mallinckrodt and Yaqrit and has received speaking fees from Grifols. RJ is the founder of Yaqrit Limited and Thoeris GmBh, which is developing UCL inventions for treatment of patients with cirrhosis.
